| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06c87200cf96acdabeae38cd1101927d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2017-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d24645da73952bb1fea9b31243a70f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f984de832eba1d4a3cc6d57d7eeae95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b791d1fea8443af1132cef3346c4047a |
| publicationDate |
2018-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201838658-A |
| titleOfInvention |
Nanoparticle contrast agent for early diagnosis of Alzheimer's disease by magnetic resonance imaging (MRI) |
| abstract |
The present invention relates to a novel nanoparticle that crosses the blood-brain barrier and forms bonds with amyloid plaques and other related protein aggregates for detection by magnetic resonance imaging (MRI). The compositions, methods of preparation, and methods of use described herein also provide a non-invasive means of early diagnosis of Alzheimer's disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109626439-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113226381-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113226381-B |
| priorityDate |
2017-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |